CN106942439A - A kind of blue or green money willow Guava Leaf blood-sugar reducing tea and its production and use - Google Patents
A kind of blue or green money willow Guava Leaf blood-sugar reducing tea and its production and use Download PDFInfo
- Publication number
- CN106942439A CN106942439A CN201710320271.9A CN201710320271A CN106942439A CN 106942439 A CN106942439 A CN 106942439A CN 201710320271 A CN201710320271 A CN 201710320271A CN 106942439 A CN106942439 A CN 106942439A
- Authority
- CN
- China
- Prior art keywords
- blood
- powder
- ultramicro
- blue
- money willow
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23F—COFFEE; TEA; THEIR SUBSTITUTES; MANUFACTURE, PREPARATION, OR INFUSION THEREOF
- A23F3/00—Tea; Tea substitutes; Preparations thereof
- A23F3/34—Tea substitutes, e.g. matè; Extracts or infusions thereof
Abstract
The invention belongs to field of health care food, and in particular to a kind of blue or green money willow Guava Leaf blood-sugar reducing tea and its production and use, and it presses 1 by blue or green money willow Ultramicro-powder and Guava Leaf Ultramicro-powder:The weight of (0.4~9) is than composition.Hypoglycemic tea component of the present invention is simple, and significantly, preparation technology is simple, low cost, effect harmless to the human body, and no resistance to the action of a drug can long-term taking for hypoglycemic effect.
Description
Technical field
The invention belongs to field of health care food, and in particular to a kind of blue or green money willow Guava Leaf blood-sugar reducing tea and preparation method thereof and
Purposes.
Background technology
Diabetes turned into the 3rd principal disease in current China's non-contagious chronic diseases (angiocardiopathy, tumour,
Diabetes), it is the serious common disease frequently-occurring disease for threatening our people healthy, brings heavy burden to national economy, have a strong impact on
The development of social economy.The speed of its growths of falling ill, is related to that crowd is wide, and consumption health resources is big, causes as many as deformity, death
Startling stage is reached.Therefore, it is China's great hygienic issues urgently to be resolved hurrily to prevent and control diabetes.
Diabetes are referred to as diabetes in traditional Chinese medicine, to drink more, diuresis, eat and become thin more, it is tired, urinate and sweet be
Principal character, diseased region is in lung, stomach and kidney.Thinking modern scholar more the basic pathogenesis of diabetes for yin jin loss, it is scorching partially
Contain.And think, with the passing of time, the state of an illness is out of control for diabetes, then yin deficiency affecting yang, heat, which are burnt, loses blood stasis, and causes impairment of both QI and YIN, deficiency in both YIN and YANG, network
Arteries and veins becomes silted up resistance, and passages through which vital energy circulates, which loses, supports, and qi and blood is inverse disorderly, internal organs organ it is impaired and occur carbuncle, dizziness, the obstruction of qi in the chest, deafness, blindness, limbs fiber crops pain, under
The accompanying symptoms such as limb gangrene, renal failure oedema, apoplectic coma.
Diabetic duration is slow, the specific medicament for curing diabetes is there is no at present, as far as possible with the small natural plant of toxic and side effect
Thing control blood sugar level is the key for treating diabetes.As Chinese patent application CN102935186B discloses a kind of prevention glycosuria
The health protection tea of disease, by 15-25 grams of dandelion, 10-20 grams of asparagus fern, 10-20 grams of the tuber of dwarf lilyturf, 5-15 grams of corn stigma, root of Chinese trichosanthes 15-25
Gram, totally 7 kinds of medicinal materials are constituted for 3-6 grams of 10-20 grams of field pennycress and schizonepeta.And for example Chinese patent application C N103157013B are disclosed
A kind of medicinal herb tea for treating diabetes, the medicinal herb tea is by kalimeris 5~10, and Chinese herbaceous peony 5~10, sword-leaved cymbidium 15~20, Chinese Ladiestresses Root or Herb 10~15, pen is young
Grass 20~25, Snakegourd Fruit 10~15, totally 7 kinds of Chinese medicines are constituted guava immature fruit 20~25.Health protection tea disclosed above has preferable treatment
The curative effect of diabetes, but have the disadvantage that：One is that health protection tea disclosed above is the conduct by the way of boiling water is brewed
Tea is drunk, it is impossible to more comprehensively, better profits from the functional component in medicinal material, it is impossible to is immediately used by the body, absorbed well；Two are
Above-mentioned health protection tea constituent is complicated, and quality control difficulties, preparation procedure is tediously long, is unfavorable for the stabilization of product quality and curative effect
Property；Three be that above-mentioned health protection tea is annotated without reference to the profound science to drug effect.
Therefore, it is necessary to provide a kind of determined curative effect, component is simple, low cost, the significant health protection tea of hypoglycemic effect.
The content of the invention
The present invention is intended to provide a kind of blue or green money willow Guava Leaf blood-sugar reducing tea and its production and use.The present invention is using super
Micropowder technology prepares a kind of blood-sugar reducing tea, its can more comprehensively, better profit from it is various water-soluble and water-insoluble in medicinal material
Effective component, makes it easier to be immediately used by the body, absorbs, and gives full play to its health-care efficacy, and its composition is simple, manufacturing process letter
Just, sanitary index is easily controllable, is easy to widely promotion and application.
In order to achieve the above object, the present invention uses following technical scheme：
A kind of blue or green money willow Guava Leaf blood-sugar reducing tea, 1 is pressed by blue or green money willow Ultramicro-powder and Guava Leaf Ultramicro-powder:(0.4~9)
Weight is than composition.
Further, the blood-sugar reducing tea presses 1 by blue or green money willow Ultramicro-powder and Guava Leaf Ultramicro-powder:The weight of (1~9) compares group
Into.
Further, the blood-sugar reducing tea presses 3 by blue or green money willow Ultramicro-powder and Guava Leaf Ultramicro-powder:7 weight is than composition.
Further, the blood-sugar reducing tea presses 1 by blue or green money willow Ultramicro-powder and Guava Leaf Ultramicro-powder:1 weight is than composition.
Further, the blue or green money willow Ultramicro-powder is made by following steps：
Blue or green money willow tender leaf or leaf bud are taken, cleans, withers, is finished, parch is kneaded, bakees, through ultramicro grinding, particle is made
Ultra-micro powder of the diameter below 75 μm, is produced.
Further, the Guava Leaf Ultramicro-powder is made by following steps：
Guava Leaf is taken, cleans, withers, is finished, parch is kneaded, bakees, through ultramicro grinding, particle diameter is made in 75 μ
Below m ultra-micro powder, is produced.
Correspondingly, present invention also offers a kind of method for preparing above-mentioned blood-sugar reducing tea, comprise the following steps：
A blue or green money willow tender leaf or leaf bud) are taken, cleans, withers, is finished, parch kneads, is bakeed, through ultramicro grinding, is made
Ultra-micro powder of the grain diameter below 75 μm, it is standby；
B Guava Leaf) is taken, cleans, withers, is finished, parch is kneaded, is bakeed, through ultramicro grinding, particle diameter is made and exists
Less than 75 μm of ultra-micro powder, it is standby；
C above-mentioned blue or green money willow Ultramicro-powder and Guava Leaf Ultramicro-powder) are taken by 1:The weight of (0.4~9) is packed, i.e., than mixing
.
In addition, auxiliary treatment type II diabetes and its complication are being prepared present invention also offers above-mentioned blood-sugar reducing tea
Purposes in health food.
Purposes as described above, the blood-sugar reducing tea can reduce the content of glycated serum protein in blood glucose and reduction blood.
The present invention has advantages below：
1) blood-sugar reducing tea of the present invention is made up according to a certain percentage of blue or green money willow and Guava Leaf, and composition is simple, and hypoglycemic effect shows
Write, and its constituent is simple, system easy to control the quality, preparation technology is simple, it is ensured that the stability of product quality, while to human body
Nonhazardous is acted on, and no resistance to the action of a drug can long-term taking.
2) present invention prepares a kind of blood-sugar reducing tea using ultrastructurepower technology, traditional " having tea " is changed into " eating tea ", energy
Enough more comprehensively, various water-soluble and water-insoluble effective component in medicinal material is better profited from, makes it easier to be immediately used by the body, inhales
Receive, give full play to its health-care efficacy.
Brief description of the drawings
Fig. 1 shows the influence of different proportion blue or green money willow of the present invention and Guava Leaf combination to formula total saposins total amount；
Fig. 2 shows that blood glucose changes over time trend after the administration of IDDM mouse；
Fig. 3 shows influence of the blue or green money willow to IDDM mouse liver cell tissue morphology；
Fig. 4 shows influence of the blue or green money willow to IDDM Mice Islet Cells tissue morphology；
Fig. 5 shows influence of the blue or green money willow extract of various dose to type II diabetes rat blood sugar；
Fig. 6 shows influence of the blue or green money willow extract of various dose to type II diabetes rat lipid metaboli；
Fig. 7 shows influence of the blue or green money willow extract of various dose to type II diabetes rat glycated serum protein.
Embodiment
The embodiment of form, further specifically to the above work of the present invention by the following examples
It is bright.But the scope that this should not be interpreted as to above-mentioned theme of the invention is only limitted to following examples.
Blood-sugar reducing tea composition of raw materials described in the embodiment of the present invention 1~3 and comparative example 1
Embodiment 4, hypoglycemic tea preparation method of the present invention
A) blue or green money willow is pre-processed：
S1, prophyll harvesting, are selected：Choose color and luster it is light green, quality is plump, disease-free spot, leaf bud or tender leaf without insect pest, wash
Only, except defoliation table dust and microorganism, drain away the water, uniformly spread out at aeration-drying；
S2, wither：Naturally withered 3h, and centre can be stirred 1 time up and down, and soft, percentage of water loss has been withered for 8% to blade；
S3, fixing：By the blue or green money willow blade parch withered fixing, make moisture continue to distribute, prevent enzymatic reaction；
S4, parch：Put the blade after fixing into frying pan, the gradient of frying pan is 35 °, and temperature control continuously stir-fries at 80 DEG C
4min, soft to blade, that holds is agglomerating, and pine does not dissipate hand, and the clear taste of news disappears, and shows slightly delicate fragrance；
S5, knead：Parch raw material is put in and rubbed on plate, every pot is firmly uniformly kneaded, and kneads 5min points for 3 times；
S6, baking：After pectin decomposer formation tight knot it is streak after, with sieve leaf bar and smalls are separated, leaf bar is put into
Quickly stir-fried in 70 DEG C of pot, bakee to hand twist with the fingers leaf bar it is in small, broken bits into powder, moisture content be less than 6%, carry out ultramicro grinding, particle is made
Ultra-micro powder of the diameter below 75 μm；
B) Guava Leaf is pre-processed：
S1, prophyll harvesting, are selected：Selection color and luster is light green, quality is plump, disease-free spot, the blade without insect pest, is eluted with water,
Except defoliation table dust and microorganism, drain away the water；
S2, boiling：500ml water is put in electric frying pan, electric frying pan is opened to 500W, and after water is boiled, Guava Leaf is placed in into boiling water
In, take the dish out of the pot, drain away the water when leaf disappears into yellow green, smelly green gas taste, has light delicate fragrance；
S3, fixing：Guava blade after boiling is again placed in electric frying pan and carries out parch fixing, makes moisture continue to dissipate
Hair, prevents enzymatic reaction；
S4, baking：Guava Leaf after fixing is placed in 90 DEG C of baking ovens, bakees in small, broken bits into powder, moisture content to hand sth. made by twisting leaf bar
Less than 6%, ultramicro grinding is carried out, ultra-micro powder of the particle diameter below 75 μm is made；
C above-mentioned blue or green money willow Ultramicro-powder and Guava Leaf Ultramicro-powder) is taken to mix, packaging is produced.
The suppression experiment of the alpha-glucosidase of embodiment 5
1. experimental method：
1.1 extract concentration
Using blood-sugar reducing tea described in comparative example 1 as positive controls, blue or green money willow and Guava Leaf are taken by 10:0、7:3、5:5、3:7
With 0:10 ratios are mixed, and take the blood-sugar reducing tea of comparative example 1 and each ratio sample 10g to be separately added into 500ml distilled water, 90 DEG C of water-baths
30min, suction filtration, filtrate concentrated by rotary evaporation to 10ml is preserved stand-by.
1.2 dilutions
By each ratio concentrate PBS dilution such as following table concentration, each test sample is obtained.
The measure of 1.3 enzymatic activitys
Added into each test sample and be separately added into 100 μ l enzyme liquids, 37 DEG C of constant temperature 15min add preheated substrates (PNPG/
PNPB) 50 μ l, 37 DEG C of constant temperature 15min, add the μ l of terminator 0.2mol/L Na2CO3 80, and ELIASA surveys absorbance.
The measure of 1.4 total glycosides contents
1.4.1 column chromatography：D101 macroreticular resins, neutral alumina dress post, successively with 70% ethanol, washing post；Precision adds
Enter 0.5ml need testing solutions, 25ml washing posts abandon eluent；Again use the ethanol elution saponin(es of 25ml 70%, collect eluent in
In evaporating dish, water-bath is volatilized.
1.4.2 chromogenic assay：Into the above-mentioned evaporating dish volatilized, the accurate vanillic aldehyde glacial acetic acid for adding 0.2m l5% is molten
Liquid, dissolved residue；Again plus 0.8ml perchloric acid, mix；Move into 5ml band plug graduated centrifuge tubes, 60 DEG C of water-bath 10min；Ice bath is cold
But after, precision add 5.0ml glacial acetic acids, after shaking up, with ELIASA at 560nm wavelength mensuration absorbance value；It is legal with external standard
Amount.As a result Fig. 1 is seen.
Fig. 1 is shown, works as blue or green money willow：Guava Leaf is 3:When 7, the total saponin content highest in formula.
1.5 calculate
Each formula group is mapped with concentration to inhibiting rate, obtains regression equation, and it to calculate by 50% when each formula group inhibiting rate
Corresponding concentration, the results are shown in Table 1.
Each blue or green money willow-Guava Leaf formula concentration when table 1 has 50% inhibiting rate to alpha-glucosidase
Note：Stronger to alpha-glucosidase inhibitory action, i.e., the concentration needed for when inhibiting rate is 50% (half inhibiting rate) is lower,
Hypoglycemic effect is better.
As shown in Table 1, Guava Leaf is eager to excel to alpha-glucosidase inhibitory action than blue or green money willow, but simple Guava Leaf mouthfeel
Difference.Separately from table 1, it is apparent that blue or green money willow and Guava Leaf are applied in combination with significantly inhibiting the effect of alpha-glucosidase, its
In with 1：The ratio combination inhibition of (1~9) is preferable, especially when blue or green money willow and Guava Leaf ratio are 3:Suppress effect when 7
Fruit is optimal, also, compared with both are used alone, consumption is used in combination less, inhibitory action is more notable.
It is pointed out that comparative example 1 is blood-sugar reducing tea described in Chinese patent application CN105211434A, with phase of the present invention
Than, formula adds fresh yacon, corn stigma, tribute chrysanthemum flower, purslane, dried orange peel, FOS, control comparative example 1 total amount and
The embodiment of the present invention is consistent, as a result shows, the hypoglycemic effect of comparative example 1 has obvious decline compared with the present invention.This point
It is that inventor is unexpected.
Effect of the blue or green money willow of embodiment 6 to IDDM mouse
Research one, influence of the blue or green money willow to IDDM mouse blood sugar
1 experimental method：
1.1 modelings
15 male mices are taken as Normal group not modeling, other male mice fasting 12h that adaptability is fed
Afterwards, abdominal cavity injection STZ 130mg/kg, Normal group abdominal cavity injection citrate buffer solution.Diet after STZ is injected, and is fitted
When supplementing 10% G/W.After two weeks, mouse fasting 12h cuts tail and takes blood, blood glucose meter surveys fasting blood-glucose, selects fasting blood-glucose
>=11.1mmol/L mouse is IDDM mouse.
1.2 animal packets are administered
3 groups will be divided into mould mouse：Model group, positive drug group (melbine Rosiglitazone Maleate Tablets, Ge Lan element histories
Gram), blue or green money willow group, every group 15, each group animal gastric infusion, daily gavage once, successive administration 21 days.Another Normal group
It is not administered, it is normal to feed.A fasting blood-glucose is surveyed at every 7 days ends of each group, observes each group change of blood sugar.
The administration experiment of 1.3 insulin injections
Fasting blood-glucose is determined after 6 IDDM mouse, fasting 12h are taken from model group.Survey after fasting blood-glucose, often
Mouse is subcutaneously injected after feeding after the parenteral solution of 0.2mL insulin asparts 30 (Novo Nordisk), insulin injection 5min, 5h respectively
Measure mouse blood sugar value.
The HE dyeing of 1.4 tissues
Etherization mouse, is cut open the belly, and passivity extracts pancreas, and clip fraction liver is fixed with 15% neutral formalin solution
Pancreas and liver, every group is selected 5 pancreas and liver specimens, specimens paraffin embedding slices at random respectively, makees HE dyeing, light Microscopic observation is simultaneously
Take the photograph piece.
2. experimental result
Result of the test is as shown in Fig. 2 gavage blue or green money willow mouse fasting blood-glucose is significantly lower than model group after being administered 7 days；And
The fasting blood sugar of each group mouse rebounds to previous level again after being administered 14 days, and is continued until that administration terminates blood glucose and all do not had
Have and lower again, compared variant but not statistically significant with model group blood glucose；And positive drug group be administered from the beginning after blood
Sugared value is not just decreased obviously sign, and positive drug group and model group blood glucose are more variant but not statistically significant, in view of this
Positive drug has no blood sugar reducing function to IDDM mouse, and result of the test is as shown in Figure 1.
Research two, influence of the insulin injection to IDDM mouse blood sugar
It can see from table 2, mouse blood sugar all lowers after insulin injection 5h, and contrast upper figure, gavage is positive
Medicine mouse blood sugar has no significant change, points out the diabetic mice that mouse is absolute insulin dependent form, can only be by injecting pancreas
Island is usually hypoglycemic.
The change (mmol/L) of IDDM mouse blood sugar after the insulin injection of table 2
| Numbering | Fasting blood-glucose | Blood glucose after insulin injection 5h |
| 1 | 28.2 | 2.7 |
| 2 | 20.6 | 1.2 |
| 3 | 20.8 | 1.8 |
| 4 | 28.0 | 1.2 |
| 5 | 16.6 | 1.2 |
| 6 | 30.7 | 3.1 |
Research three, influence of the blue or green money willow to IDDM mouse liver tissue morphology
Abdominal cavity injection STZ induction IDDM mouse models, insulin injection checking model, difference gavage model
Mouse positive drug (melbine Rosiglitazone Maleate) and blue or green money willow Aqueous extracts, observation normal mouse and each administration group Mouse Liver
Dirty, pancreatic tissue structure, as a result as shown in figs. 34.
Fig. 3 is shown：
Normal group (A)：Liver, pancreatic tissue structural form：It is mouse liver structural integrity, clear；Liver cell arranges
Rule, radially distributes around central vein；Hepatic sinusoid change without exception, clear in structure；Endochylema is uniform, and form is normal.
Model group (B)：Mouse liver cell arrangement disorder, the obvious steatosis of liver cell, karyon and endochylema separation；Positive drug
Group (C)：Mouse lobuli hepatis boundary is relatively clear, and hepatic cell fattydegeneration is reduced, and liver cell arrangement is relatively regular；Blue or green money willow Aqueous extracts
Group (D)：Mouse lobuli hepatis structure is clear, and hepatic cell fattydegeneration is significantly reduced, liver cell queueing discipline, around central vein
Radially distribute, endochylema is more uniform, form is normal.
Fig. 4 is shown：
Normal group (A)：Boundary clear between pancreas islet and exocrine gland in the visual field, pancreas islet form is completely regular, pancreas islet
Inner cell arrangement is close and is evenly distributed, and number is more.Model group (B)：Boundary is relative between pancreas islet and exocrine gland in the visual field
Fuzzy, pancreas islet atrophy, form is irregular, part islet cells endochylema and karyon separation, there is vacuolar degeneration.Positive drug group (C)：Depending on
Boundary is clearer between Yezhong pancreas islet and exocrine gland, and pancreas islet form is completely regular, and the arrangement of pancreas islet inner cell is close, vacuolar degeneration
Significantly reduce.Blue or green money willow Aqueous extracts group (D)：Boundary clear between pancreas islet and exocrine gland in the visual field, pancreas islet form is completely regular,
Pancreas islet inner cell is evenly distributed, and number is more.
It will thus be seen that positive drug group and blue or green money willow water extraction liquid energy improve absolute insulin dependent form IDDM mouse
Liver organization form and islet cells form, illustrate that blue or green money willow Aqueous extracts have certain protective role to liver and pancreatic tissues.
The effect of embodiment 7, blue or green money willow to type II diabetes rat
1. experimental method：
1.1 modelings
Take 12 male rats as Normal group not modeling, other rats feed high lipid food and (contain basal feed
74.5%, cholesterol 1%, yolk powder 5%, sucrose 10%, lard 9%, sodium taurocholate 0.5%；In Guangdong Province medical experiment animal
The heart) after one month, fasting 12h, abdominal cavity injection STZ 40mg/kg, Normal group abdominal cavity injection citrate buffer solution.Injection
10% G/W of appropriate supplement after STZ.After two weeks, Rat Fast 12h cuts tail and takes blood, blood glucose meter surveys fasting blood-glucose, and selection is empty
Abdomen blood glucose >=11.1mmol/L rat is type II diabetes rat.
2. animal packet is administered
3 groups will be divided into mould rat：Model group, positive drug group (melbine Rosiglitazone Maleate Tablets, Ge Lan element histories
Gram), blue or green money willow group, every group 15.Each group animal gastric infusion, once a day, feeding normal diet.Successive administration 3 months.Just
Normal control group is not administered, normal to feed.A fasting blood-glucose and body weight are surveyed in every 7 days ends of each group.Each group monthly take a blood sample by the end of month eye socket,
Blood glucose meter determines blood glucose, and Ketoamine oxidase method determines glycated serum protein (GSP) value of each group rat, and by whole blood centrifuging and taking blood
Clearly, serum Song Zhi hospitals are measured into blood lipids.
3. statistical method
Indices represent that the significance test of difference is examined using t between two groups of means with mean ± standard deviation (x ± s)
Method.
With high lipid food and abdominal cavity injection STZ induction type II diabetes rat animal models, gavage model mice is positive respectively
Property medicine (melbine Rosiglitazone Maleate) and various dose blue or green money willow Aqueous extracts, statistics normal rat and each administration group rat
Fasting blood-glucose change, lipid metaboli index and glycated serum protein, as a result as shown in Fig. 5~7, in Fig. 7△Model group and blank group ratio
Compared with,△△P<0.01；▲Compared with model group,▲P<0.05,▲▲P<0.01。
As a result show that blue or green money willow water extraction liquid energy reduction type II diabetes rat fasting blood-glucose makes atherosclerosis (AS)
Risk factor (T-CHOL, triglycerides and low-density lipoprotein) and glycated serum protein content reduction, point out blue or green money willow
Aqueous extracts have certain adjustment effect to glycolipid metabolism, and hypoglycemic effect is notable.
Claims (10)
1. a kind of blue or green money willow Guava Leaf blood-sugar reducing tea, it is characterised in that press 1 by blue or green money willow Ultramicro-powder and Guava Leaf Ultramicro-powder:
The weight of (0.4~9) is than composition.
2. blood-sugar reducing tea as claimed in claim 1, it is characterised in that press 1 by blue or green money willow Ultramicro-powder and Guava Leaf Ultramicro-powder:(1
~weight 9) is than composition.
3. blood-sugar reducing tea as claimed in claim 2, it is characterised in that press 3 by blue or green money willow Ultramicro-powder and Guava Leaf Ultramicro-powder:7
Weight than composition.
4. blood-sugar reducing tea as claimed in claim 2, it is characterised in that press 1 by blue or green money willow Ultramicro-powder and Guava Leaf Ultramicro-powder:1
Weight than composition.
5. the blood-sugar reducing tea as described in Claims 1 to 4 is any, it is characterised in that the blue or green money willow Ultramicro-powder is by following steps system
：
Blue or green money willow tender leaf or leaf bud are taken, cleans, withers, is finished, parch is kneaded, bakees, through ultramicro grinding, particle diameter is made
Ultra-micro powder below 75 μm, is produced.
6. the blood-sugar reducing tea as described in Claims 1 to 4 is any, it is characterised in that the content of total saposins is 3.0 in the blood-sugar reducing tea
~6.0mg/g.
7. the blood-sugar reducing tea as described in Claims 1 to 4 is any, it is characterised in that the Guava Leaf Ultramicro-powder is by following steps
It is made：
Take Guava Leaf, clean, wither, finish, parch kneads, bakee, through ultramicro grinding, be made particle diameter 75 μm with
Under ultra-micro powder, produce.
8. a kind of method for preparing the blood-sugar reducing tea as described in claim 1~7 is any, it is characterised in that comprise the following steps：
A blue or green money willow tender leaf or leaf bud) are taken, cleans, withers, is finished, parch is kneaded, bakees, through ultramicro grinding, particle is made straight
Ultra-micro powder of the footpath below 75 μm, it is standby；
B Guava Leaf) is taken, cleans, withers, is finished, parch is kneaded, bakees, through ultramicro grinding, particle diameter is made at 75 μm
Following ultra-micro powder, it is standby；
C above-mentioned blue or green money willow Ultramicro-powder and Guava Leaf Ultramicro-powder) are taken by 1:The weight of (0.4~9) is produced than mixing, packaging.
9. purposes of the blood-sugar reducing tea in auxiliary treatment type II diabetes health food is prepared as described in claim 1~8 is any.
10. purposes as claimed in claim 9, it is characterised in that described blood-sugar reducing tea can be reduced in blood glucose and reduction blood
The content of glycated serum protein.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201710320271.9A CN106942439B (en) | 2017-05-09 | 2017-05-09 | Cyclocarya paliurus and guava leaf blood glucose reducing tea and preparation method and application thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201710320271.9A CN106942439B (en) | 2017-05-09 | 2017-05-09 | Cyclocarya paliurus and guava leaf blood glucose reducing tea and preparation method and application thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN106942439A true CN106942439A (en) | 2017-07-14 |
| CN106942439B CN106942439B (en) | 2019-12-20 |
Family
ID=59478412
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201710320271.9A Expired - Fee Related CN106942439B (en) | 2017-05-09 | 2017-05-09 | Cyclocarya paliurus and guava leaf blood glucose reducing tea and preparation method and application thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN106942439B (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN108850301A (en) * | 2018-08-01 | 2018-11-23 | 河南省农业科学院 | A kind of preparation method of Chinese toon hypoglycemic tea bag |
Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1887102A (en) * | 2005-07-02 | 2007-01-03 | 刘新华 | Qingqian willow health tea and its production process |
| CN101797000A (en) * | 2010-03-02 | 2010-08-11 | 浙江大学 | Preparation method of ultramicro mulberry leaf tea powder |
| CN102217686A (en) * | 2011-06-02 | 2011-10-19 | 王乃利 | Hypoglycemic tea and preparation method thereof |
| CN102422926A (en) * | 2011-11-09 | 2012-04-25 | 肖梅芬 | Cassia obtusifolia tea bag with functions of weight reduction, hypotension and hypoglycemic effect and its production process |
| CN103461997A (en) * | 2013-08-13 | 2013-12-25 | 娄志 | Hypoglycemic composite fruit and vegetable powder and preparation method thereof |
| CN105519721A (en) * | 2015-12-31 | 2016-04-27 | 广东国方医药科技有限公司 | A tea bag containing moringa tree leaves and a preparing method thereof |
-
2017
- 2017-05-09 CN CN201710320271.9A patent/CN106942439B/en not_active Expired - Fee Related
Patent Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1887102A (en) * | 2005-07-02 | 2007-01-03 | 刘新华 | Qingqian willow health tea and its production process |
| CN101797000A (en) * | 2010-03-02 | 2010-08-11 | 浙江大学 | Preparation method of ultramicro mulberry leaf tea powder |
| CN102217686A (en) * | 2011-06-02 | 2011-10-19 | 王乃利 | Hypoglycemic tea and preparation method thereof |
| CN102422926A (en) * | 2011-11-09 | 2012-04-25 | 肖梅芬 | Cassia obtusifolia tea bag with functions of weight reduction, hypotension and hypoglycemic effect and its production process |
| CN103461997A (en) * | 2013-08-13 | 2013-12-25 | 娄志 | Hypoglycemic composite fruit and vegetable powder and preparation method thereof |
| CN105519721A (en) * | 2015-12-31 | 2016-04-27 | 广东国方医药科技有限公司 | A tea bag containing moringa tree leaves and a preparing method thereof |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN108850301A (en) * | 2018-08-01 | 2018-11-23 | 河南省农业科学院 | A kind of preparation method of Chinese toon hypoglycemic tea bag |
Also Published As
| Publication number | Publication date |
|---|---|
| CN106942439B (en) | 2019-12-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Club et al. | Fenugreek (Trigonella foenum-graecum L.) as a valuable medicinal plant | |
| CN103750107B (en) | Health-care product with blood glucose reducing function | |
| CN101327014A (en) | Food specially formulated for diabetes and preparation method thereof | |
| CN106176918A (en) | A kind of Hyperglycemic health care compositions comprising leaf of Cyclocarya paliurus Iljinskaja and Radix Puerariae | |
| CN105963514A (en) | Traditional Chinese medicine product for treating diabetes and preparation method | |
| CN102526479A (en) | Health-care medicine formula with functions of enhancing immunity and lowering blood sugar | |
| CN102526478A (en) | Formula of health-care medicine with functions of strengthening immunity and reducing blood sugar | |
| CN101543295B (en) | Health care tea for reducing blood pressure and blood fat | |
| CN107982318A (en) | A kind of Traditional Chinese medicine for decreasing blood sugar compound | |
| CN105030984A (en) | Lychee seed health oral liquid for reducing blood glucose, regulating blood lipid and relieving diabetic complications as well as preparation method of lychee seed health oral liquid | |
| CN109694805A (en) | A kind of formula and preparation method thereof of the friendly tender tea leaves alcoholic drink mixed with fruit juice of sugar | |
| CN106942439A (en) | A kind of blue or green money willow Guava Leaf blood-sugar reducing tea and its production and use | |
| CN110201011A (en) | Euscaphis konishii extract is preparing the application in blood lipid-lowering medicine | |
| CN105012826A (en) | Alpinia oxyphylla leaf extract and preparation method and application thereof | |
| CN105077467A (en) | Health-care abalone-sea cucumber beverage with blood sugar-reducing function | |
| CN108260682A (en) | A kind of hypoglycemic, reducing blood lipid and the health protection tea of blood pressure lowering | |
| CN108041558A (en) | A kind of health soy sauce and preparation method thereof | |
| CN107712890A (en) | A kind of antitoxic heart-soothing and sedative cream taste and preparation method thereof | |
| CN104474103B (en) | A kind of natural plant hypoglycemic agent and preparation method thereof | |
| CN106692760A (en) | Golden flower wine formula for preventing diabetes and preparation method thereof | |
| CN109730174A (en) | A kind of tea for reducing hypertension and fat | |
| CN108936652A (en) | A kind of health-care fruit jelly and preparation method thereof of hypoglycemic decompression | |
| CN108391815A (en) | A kind of ease constipation Weight reducing compound and preparation method | |
| CN114558051B (en) | Chinese medicinal composition for treating diabetes and preparation method thereof | |
| CN109007161A (en) | A kind of gynostemma pentaphylla hypoglycemic blood pressure depressing health tea and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20191220 |